INT MEDICAL (01501) announced that the company has submitted a filing to the China Securities Regulatory Commission (CSRC) for the implementation of full circulation of its H shares. According to the CSRC filing, the company has applied on behalf of certain shareholders to convert a total of 71.7866 million domestic shares held by these shareholders into H shares and list them on the Hong Kong Stock Exchange (HKEX).
Upon obtaining all necessary filings and/or approvals from relevant regulatory authorities, including the CSRC and HKEX, and complying with all applicable laws, regulations, and rules, these domestic shares will be converted into H shares and listed for trading on the Main Board of HKEX.
In accordance with the company's articles of association, no shareholders' meeting is required to approve the conversion and listing.
Comments